SCHEMBL4437749

SCHEMBL4437749

CS(=O)(=O)Nc1c(F)cc(CCN)c(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38
HTR2A P28223 3/20 0.33
HTR2C P28335 3/20 0.33
HTR2B P41595 3/20 0.33
KDM1A O60341 1/20 0.33
MAOA P21397 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
HTR6 P50406 1/20 0.32
TAAR1 Q96RJ0 2/20 0.32
MEN1 O00255 2/20 0.32
RAD52 P43351 2/20 0.32
RECQL P46063 2/20 0.32
KMT2A Q03164 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
GAPDH P04406 1/20 0.32
THRB P10828 1/20 0.32
APEX1 P27695 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4433088 0.91 ADRA2C (0.37) ADRA2CADRA1AADRA1BKDM1AMAOA
SCHEMBL3780898 0.89 ADRA2C (0.39) ADRA2CADRA1AADRA1BKDM1AMAOA
SCHEMBL4437406 0.80 TGM2 (0.32) CA1CA2
SCHEMBL957737 0.78 ADRA2C (0.41) ADRA2CADRA1AADRA1BHTR6
Hydrochloric Acid SCHEMBL3362498 0.77 ADRA2C (0.40) ADRA2CADRA1AADRA1B
SCHEMBL955620 0.73 ADRA2C (0.42) ADRA2CADRA1AADRA1BKDM4E
SCHEMBL3364600 0.72 ADRA2C (0.39) ADRA2CADRA1AADRA1BHTR6
SCHEMBL3782011 0.72 ADRA2C (0.40) ADRA2CADRA1AADRA1B
SCHEMBL3782008 0.72 ADRA2C (0.40) ADRA2CADRA1AADRA1B
SCHEMBL4443621 0.72 TGM2 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054411-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2009-05-06 EP disclosed
WO-2008013414-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2008-01-31 WO disclosed